Tsumura & Co. (4540.T) JPX
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
Tsumura & Co.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4923
First IPO Date
January 01, 2001
Key Executives
| Name | Title | Pay | Year Born |
| Terukazu Kato | President, Chief Executive Officer & Chairman | 119M | 1963 |
| Kaoru Kobayashi | Chief Financial Officer & Head of the Corporate Management Division | 0 | N/A |
| Toshio Yamaoka | Executive Officer and Head of Pharmaceutical Sales & Marketing Division | 0 | N/A |
| Zhang Lixian | Executive Officer & China Production Manager and China Pharmaceutical Platform Manager | 0 | N/A |
| Kazushige Mizoguchi | Executive Officer and Head of Quality Assurance Division & Safety Management Division | 0 | N/A |
| Kei Sugii | COO & Representative Director | 0 | 1969 |
| Akihito Konda | CTO, Head of Research & Development Division and Director | 0 | 1969 |
| Shoichi Kumagai | GM, Head of Production Division & Executive Officer | 0 | N/A |
| Kouji Shiseki | Executive Officer & Head of Corporate Secretary Division | 0 | N/A |
| Yoshiharu Watanabe | Executive Officer & Chinese Herbal Medicine Platform Director | 0 | N/A |
| Makoto Kitamura | Head of Corporate Communications Dept. | 0 | N/A |
Description
Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus on Kampo extract intermediates and granular Kampo preparations. Its operations are comprehensive, encompassing the full supply chain: from the careful acquisition, selection, processing, and warehousing of raw herbal materials and crude drug components for decoctions, to the manufacturing of powdered Kampo extracts and traditional Chinese medicines. Additionally, Tsumura & Co. is engaged in the sale of both pharmaceutical goods and food products.
